this article reviews the financial and business updates of acorda therapeutics ( n=2022 ). we describe the growth of the brand in the usa and ex - usa in 2023. we describe the growth of the brand in the usa and ex - usa in 2023. we also provide a review of the current issues and the current progress in our research and development and management. we will discuss the issues that we have experienced in the past and how we will continue to build shareholder value in 2023.